Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

Emiliano Trías(Institut Pasteur de Montevideo), Luis Barbeito(Institut Pasteur de Montevideo)

Journal of Neuroinflammation

July 5, 2016

10.1186/s12974-016-0620-9

Cited by 148

Related Papers

Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I

|PLoS ONE|2011|62